Je-Seong Won to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Je-Seong Won has written about Carcinoma, Hepatocellular.
Connection Strength
0.175
-
Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2017 Jan; 32(1):199-207.
Score: 0.119
-
[Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis]. Korean J Hepatol. 2006 Mar; 12(1):65-73.
Score: 0.056